Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And Toxoplasmosis
    66.
    发明申请
    Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And Toxoplasmosis 审中-公开
    蛋白质抗原的方法和组成用于弓形虫感染和弓形体病的诊断和治疗

    公开(公告)号:US20140004141A1

    公开(公告)日:2014-01-02

    申请号:US13997603

    申请日:2011-12-20

    IPC分类号: C07K14/45

    摘要: Contemplated compositions, devices, and methods are drawn to various antigens from the pathogen T. gondii and their use in various diagnostic tests, vaccines, and therapeutic agents. In particularly preferred aspects, the antigens are immunodominant and have quantified and known relative reactivities with respect to sera of a population infected with the pathogen, and/or have a known association with a disease parameter.

    摘要翻译: 将考虑的组合物,装置和方法绘制到来自病原体弓形虫的各种抗原及其在各种诊断测试,疫苗和治疗剂中的用途。 在特别优选的方面,抗原是免疫显性的,并且相对于感染病原体的群体的血清具有定量和已知的相对反应性,和/或具有与疾病参数的已知关联。

    Chimeric recombinant antigens of Toxoplasma gondii
    68.
    发明授权
    Chimeric recombinant antigens of Toxoplasma gondii 失效
    弓形虫的嵌合重组抗原

    公开(公告)号:US07867503B2

    公开(公告)日:2011-01-11

    申请号:US11899754

    申请日:2007-09-06

    IPC分类号: A61K39/012

    摘要: A method for treatment or prevention of Toxoplasma gondii infections pharmaceutical composition comprising an antigen fragments of Toxoplasma gondii in the form of a chimeric fusion product or a nucleotide sequence coding for the chimeric fusion product and a method of using the chimeric fusion product or nucleotide sequence coding therefor.

    摘要翻译: 用于治疗或预防弓形虫感染药物组合物的方法,其包含嵌合融合产物形式的弓形体的抗原片段或编码嵌合融合物的核苷酸序列的方法,以及使用嵌合融合产物或核苷酸序列编码 因此。

    Novel Polypeptides Inducing Dendritic Cell Migration, as Well as Medicines and Pharmaceutical Compositions Containing Same
    70.
    发明申请
    Novel Polypeptides Inducing Dendritic Cell Migration, as Well as Medicines and Pharmaceutical Compositions Containing Same 审中-公开
    诱导树突状细胞迁移的新型多肽,以及含有其的药物和药物组合物

    公开(公告)号:US20100160219A1

    公开(公告)日:2010-06-24

    申请号:US12226744

    申请日:2007-04-27

    CPC分类号: C07K14/45

    摘要: The invention concerns a polypeptide corresponding to amino acids 26 to 75 of the sequence of GRA5-RH protein of SEQ ID No 1: MASVKRVWAVMIVNVLALIFVGVAGSTRDVGSGGDDSEGARGRE QQQVQQHEQNEDRSLFERGRAAVT-GHPVRTAVGLAAAWAWSLL RLLKRRRRRAIQEESKESATAEEEEVAEEE, its variants acting on dendritic cell migration, homologues acting on dendritic cell migration, and fragments thereof acting on dendritic cell migration, as well as the pharmaceutical compositions thereof comprising such polypeptides and their use for making a medicine for preventing or treating skin and mucous membrane conditions involving dendritic cells or Langerhans cells.

    摘要翻译: 本发明涉及对应于SEQ ID No 1:MASVKRVWAVMIVNVLALIFVGVAGSTRDVGSGGDDSEGARGREQQQQQHEQNEDRSLFERGRAAVT-GHPVRTAVGLAAAWAWSLL RLLKRRRRRAIQEESKESATAEEEEVAEEE的GRA5-RH蛋白序列的氨基酸26至75的多肽,其作用于树突状细胞迁移的变体,作用于树突细胞迁移的同系物及其片段 作用于树突细胞迁移,以及其包含这些多肽的药物组合物及其用于制备用于预防或治疗涉及树突状细胞或朗格汉斯细胞的皮肤和粘膜病症的药物的用途。